Water Cooler Chat Session: Clinical Supply Distribution Strategy – Planning & Adapting | Recorded September 30, 2020

A clinical distribution plan must be solid enough to begin planning activities, and flexible enough to adapt to inevitable changes. A good distribution plan starts with a clear idea of what countries the trial will be held in so that decisions can be made regarding the sourcing of the product, country label requirements, whether a depot is required, and QP considerations as needed.

In adapting a distribution plan to real-time changes, clinical supply managers must have mitigation strategies, a good foundation on how to adapt IRTs as necessary, and whether drugs can be returned for reuse. 

Neil Fox, PCI’s Senior Clinical Supply Manager, also discusses:

  • How to choose between central or decentralized sourcing
  • Practices in grouping countries for label requirements
  • Having well-defined processes in place to move inventory between sites, from depot to depot, or between countries (where possible) – and why it is never justified to move drugs purely for cost reasons

When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?

Your bridge between life-changing therapies and patients